Pharmaceutical
| Wed 30 Sep 2026
Geneva, Sept. 29 -- Hoffmann La Roche Inc and Roche have submitted a patent application for TREM2 Agonists. O'hara Fionn Susannah, Stenzhorn Yannick Philip, Caramenti Paola, Brom Virginie Sacha, Zeidan Nicolas, Charpentier Julie, Boddy Alexander Joseph, Galley Guido, Di Francesco Maria Emilia, Berchtold Stefan, Gobbi Luca Claudi..